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ABSTRACT: Egyptian rice bran was fermented with baker’s yeast, and
released phenolics were extracted with aqueous methanol to give
fermented rice bran extract (FRBE). The analysis of the FRBE with
ultra-performance liquid chromatography−electrospray ionization−tandem mass spectrometry revealed 21 compounds, mainly phenolic acids
and ﬂavonoids. The FRBE was then complexed with (2-hydroxypropyl)-βcyclodextrin (HPβCD) via noncovalent host−guest inclusion complexation using the thin-ﬁlm hydration technique to improve the hydrophilicity
and bioactivity of the FRBE. The formation of the inclusion complex was
conﬁrmed using HPLC, 1H NMR, FT-IR, and a phase solubility study. In
addition, the biological activities of the complex were investigated. The
FRBE/HPβCD inclusion complex had more pronounced antioxidant,
antiviral, and anticancer activities compared to free FRBE. These ﬁndings
warrant the future investigation of potential medical applications of FRBE.
rats.9 Additionally, fermented rice bran extract showed an antiphotoaging eﬀect on UV-induced normal skin ﬁbroblast
cultures10 and eﬀectively reduced cytotoxicity and inhibited
melanogenesis in B16F1 melanoma.11 Despite its promising
biomedical applications, fermented rice bran suﬀers some
drawbacks that might hinder its clinical use, such as low
hydrophilicity, poor bioavailability, and inability to selectively
target the organ of interest. Many delivery vehicles were
reported to successfully improve the therapeutic eﬀects of
various natural and synthetic drugs via either encapsulation or
complexation,12 including nanocapsules,13 chitosan-coated
poly(lactic-6-glycolic acid) (PLGA) nanoparticles, supramolecules,14,15 liposomes,16 and PLGA−PEG nanoparticles.17,18
Cyclodextrins (CDs) and their derivatives are amphiphilic
supramolecular systems widely used as host molecules to
accommodate various therapeutically active guest molecules
via noncovalent inclusion complexation.18,19 The resulting
host−guest inclusion complexes display improved water

1. INTRODUCTION
Rice bran is a nutrient-rich byproduct that is primarily used as
a low-cost cattle feed or discarded as waste.1 The bran
constitutes about 10% of the weight of a rice grain and is rich
in nutritional components and bioactive phytochemicals such
as vitamin E (tocopherols and tocotrienols), γ-oryzanol, and
phenolics,2,3 which may positively aﬀect human health.
The content of phenolic acids in rice bran is relatively high;
however, nearly 70% of them are present in the ester form with
the arabinoxylans present in cell walls.2,4 Accordingly, these
compounds have reduced bioavailability. Phenolic acids can be
released from their esters by either incubating them with
extracellular phenolic esterase and xylanase enzymes or microorganism fermentation. For industrial applications, fermentation with food-grade micro-organisms is considered a costeﬀective and aﬀordable process for liberating and extracting
phenolic acids from rice bran powder and increasing their
antioxidant activities. Saccharomyces cerevisiae (commercially
known as baker’s yeast) has been the most common organism
used in baking and brewing since ancient times. Bread
containing fermented wheat bran was reported to have better
phenolic content and antioxidant activity.5 Being a costeﬀective and highly available source with generally recognized
as safe (GRAS) status, S. cerevisiae produces enzymes like βglucosidases, carboxylesterases, and possibly feruloyl esterases.6−8 The aqueous extract of baker’s yeast-fermented
rice bran demonstrated antistress and antifatigue eﬀects on
© 2022 The Authors. Published by
American Chemical Society

Received: March 3, 2022
Accepted: May 17, 2022
Published: June 1, 2022

19545

https://doi.org/10.1021/acsomega.2c01281
ACS Omega 2022, 7, 19545−19554

ACS Omega

http://pubs.acs.org/journal/acsodf

solubility, bioavailability, and physicochemical and biological
properties. In particular, (2-hydroxypropyl)-β-cyclodextrin
(HPβCD) is an extensively used CD derivative due to its
biocompatibility and high hydrophilicity.18,19
In this study, the methanolic extract of fermented Egyptian
rice bran (FRBE) powder containing ferulic acid as a marker
phenolic compound was prepared. The FRBE was then
complexed with (2-hydroxypropyl)-β-cyclodextrin (FRBE/
HPβCD) using the thin-ﬁlm hydration approach to improve
the water solubility of FRBE and hence enhance its biological
activities. The designed complex was characterized using 1H
NMR spectroscopy, a phase solubility study, and Fourier
transform infrared spectroscopy (FT-IR). Furthermore, the
antioxidant, antiviral, and cytotoxic activities were investigated
for both free FRBE and the FRBE/HPβCD complex.

Article

ical proﬁle and ferulic acid contents of FRBE and RBE were
determined by HPLC as described below (Figure S1).
2.4.1. HPLC Apparatus and Conditions. An Agilent 1100
serial system (Agilent Technologies, Palo Alto, CA) equipped
with a quaternary pump and a G1322A-series1200 online
degasser was used. Agilent Chemstation software was used for
data acquisition and processing. The HPLC analysis was
carried out on a reversed-phase column (C18, 5 μm particle
size, 250 × 4 mm column, Merck, Germany) provided with a
C-18 guard column, and the temperature was maintained at 25
°C. The mobile phase was composed of acetonitrile (solvent
A) and 0.3% H3PO4 in H2O (solvent B) using the gradient
elution mode from 18% A/B to 35% A/B in 17 min, then
100% A in 1 min, at a ﬂow rate of 1 mL/min and an injection
volume of 20 mL. UV detection was set at 325 nm.
2.4.2. HPLC Quantiﬁcation of Ferulic Acid (FA). The
content of ferulic acid (FA), the major phenolic acid in the
RBE and FRBE, was determined by HPLC using a standard
curve of FA. The standard curve of FA was constructed by
dissolving an aliquot (4 mg) of FA (Sigma-Aldrich Chemical
Co., St. Louis, MO) in 5 mL of methanol. The solution (800
mg/mL) was stored at 4 °C. Five serial concentrations of the
stock solution in methanol, namely 2.56, 6.40, 12.8, 32.0, and
64.0 mg/mL, were prepared. Aliquots (20 mL) of each were
injected in triplicate in the HPLC system, and the calibration
curve was constructed by plotting the mean peak area versus
the concentration. Linearity was assessed by the linear
regression method and calculated by the least-squares method.
The correlation coeﬃcient (R2) of the standard calibration
curve was 0.9998, and the linearity of the peak of FA was in the
concentration range of 2.56−64.0 mg/mL.
Then, 50 mg samples of powdered FRBE and RBE were
transferred to a 5 mL measuring ﬂask and reconstituted in 50%
aqueous methanol with sonication. The measuring ﬂask was
completed to the mark with the solvent, and the sample was
ﬁltered through a 0.45 mm membrane ﬁlter before HPLC
analysis. The FA contents in FRBE and RBE were calculated to
be 0.697 ± 0.011 and 0.318 ± 0.011 mg/g extract, respectively.
2.5. UPLC/ESI-MS-MS Analysis of the Fermented Rice
Bran Extract. The LC-MS-MS characterization was carried
out on Xevo TQD triple quadrupole system (Waters
Corporation, Milford, MA) equipped with an ESI source.
The ion trap MS system was coupled to a UPLC instrument
equipped with a reversed-phase C-18 column (Acquity UPLC
BEH C18 column, 1.7 μm particle size, 2.1 × 50 mm column).
The analysis was performed according to the method and
parameters that were developed by Bakr et al. 2021,22 with
slight modiﬁcations in the mobile phase gradient ﬂow as
follows: 0−2 min, 5% B; 2−5 min, 5−20% B; 5−15 min, 20−
30% B; 15−22 min, 30−50% B; 22−25 min, 50%B; 25−26
min, 50−80% B; 26−29 min, 80−5%; and 29−30 min, 5% B.
Solvent A was water and solvent B was acetonitrile, and both
were acidiﬁed with 0.1% formic acid.
2.6. Fabrication of the Methanolic Extract of the
Fermented Egyptian Rice Bran Extract−(2-Hydroxypropyl)-β-cyclodextrin Host−Guest Complex (FRBE/
HPβCD). The FRBE/HPβCD host−guest complex was
prepared by thin-ﬁlm hydration.23 Concisely, the FRBE
powder was dissolved in a suﬃcient amount of methanol.
Then, the resulting solution was evaporated under reduced
pressure in a round-bottom ﬂask using a rotary evaporator to
form a thin ﬁlm. Afterward, the thin ﬁlm was hydrated with a
HPβCD solution (5% w/v). The obtained complex solution

2. MATERIALS AND METHODS
2.1. Materials. 2-Hydroxypropyl-β-cyclodextrin was purchased from BLD Pharmatech Co., Limited (Cincinnati, OH).
Streptomycin, penicillin, fetal bovine serum, trichloroacetic
acid (TCA), Dulbecco’s modiﬁed Eagle’s medium (DMEM),
and tris(hydroxymethyl)aminomethane (TRIS) were obtained
from Lonza (Basel, Switzerland). 2,2-Diphenyl-1-picryl-hydrazyl-hydrate (DPPH), 2,4,6-tripyridyl-6s-triazine (TPTZ), and
FeCl3·6H2O were purchased from Sigma-Aldrich (St. Louis,
MO). The antimycotic solution and trypsin-EDTA were
obtained from Gibco BRL (Grand Island, NY).
2.2. Plant Materials. Heat-stabilized Egyptian rice bran
(RB) was obtained from International Trade and Marketing
Company (Giza, Egypt). The RB powder used was harvested
from the short-grain Japonica rice (Sakha 101) cultivar and
composed of 14% fats, including 1.5% free fatty acids; 13%
protein, including 7.2% leucine 7.2%, 4.5% lysine, and 4.2%
valine; and carbohydrates, including 1.1% fermentable sugars
and 25% dietary ﬁber.
2.3. Fermentation of Rice Bran with Commercial
Baker’s Yeast. Fermentation was performed as reported
elsewhere20,21 with a slight modiﬁcation. A sample of the heatstabilized Egyptian rice bran powder (500 g) was sieved
through a 40 mesh sieve and subjected to solid-state
fermentation with previously hydrated (with 90 mL of sterile
water for 1 h) commercial baker’s yeast (3% w/w). Then, the
activated yeast was added to the medium, and the mixture was
homogenized. Sterile water was added gradually to make a
dough (the ratio of sieved rice bran powder to water was 1:1.5
w/v). The dough was spread in an oven tray, covered with
sterile gauze, and statically incubated in the dark at 37 °C for
48 h (the humidity in the incubation area was between 60%
and 70%). The dough was left to dry in an oven at 50 °C for 24
h. The dried mass was ground, passed through mesh (420
μm), packed in polyethylene bags (labeled as fermented
powder), and stored at −30 °C for future use. Similarly, a
sample of RB powder (500 g) treated with the same procedure
was hydrated with sterile water (90 mL without baker’s yeast)
and processed as above to give the control powder.
2.4. Preparation of Methanolic Extracts (FRBE and
RBE). The dried powder (100 g of the fermented or control
powder) was separately extracted with 50% methanol (500 mL
× 3) using a sonication bath for 15 min. The extracts were
separately concentrated under reduced pressure and freezedried to give FRBE (13.5 g) and RBE (12.4 g) from the
fermented and control samples, respectively. The phytochem19546
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Figure 1. UPLC-ESI-MS/MS ion chromatogram (in the negative ion mode) of the fermented rice bran extract, which was separated on an
ACQUITY UPLC-BEH C18 1.7 μm and 2.1 × 50 mm column.

Table 1. LC-MS-MS Analysis in the Negative Mode of the Fermented Rice Bran Extract
no.

name

Rt

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

unidentiﬁed nitrogenous compound
pantolactone
gluconic acid
succinic acid
citric acid
cinnamic acid
irilone
2-octanal
apigenin-6/8-C-pentoside-8/6-C-hexoside
pentadecanoic acid
heptanal
tectoridin
p-coumaric acid
hispidulin
ferulic acid
p-hydroxybenzoic acid
coumaroylquinic acid
methyl stearate
hydroxyeicosanoic acid
dimethyl quercetin
methyl palmitate

1.31
1.34
1.58
3.02
3.05
3.96
3.99
4.01
10.05
10.31
11.18
12.01
12.05
12.09
12.87
18.1
18.19
18.3
22.43
22.97
28.61

molecular formula

MS1 [M − H]−

C6H10O3
C6H12O7
C4H6O4
C?H?O?
C9H8O2
C16H10O6
C8H14O
C26H28O14
C15H30O2
C7H14O
C22H22O11
C9H8O3
C16H12O6
C10H10O4
C7H6O3
C16H18O8
C19H38O2
C20H40O3
C17H14O7
C17H34O2

194
129
195
117
191
147
297
125
563
241
113
461
163
299
193
137
337
297
327
329
293

MS2
176,
127
129,
99,
129,
103
205,
97,
503,
223,
85,
325,
119
284
178,
93
191,
ND
ND
283
ND

refs

149, 74, 59
99, 75, 59
73
111, 87, 85
93
55
473, 383
195
69
279

149, 134, 106
119

29
30
37
30,37
31
32
29
33
34
29
32
31,32,37,38
32
31,32,37,38
37,38
32
35
36
32
35

on a 400 MHz FT-NMR spectrometer (ECA-500, JEOL,
Tokyo, Japan) in deuterium oxide using a scanning range of
1−13 ppm.
2.8. FT-IR Spectroscopy of the FRBE/HPβCD Inclusion
Complex. The FT-IR spectra of free FRBE, HPβCD, and the
prepared inclusion complex were recorded via Fourier
transform infrared (FT-IR) spectroscopy using an FTIR8400s (Shimadzu, Japan) spectrometer. Samples were ﬁrst
compressed with KBr into disks and then scanned, and spectra
were recorded in the range of 500−4000 cm−1.
2.9. Phase Solubility Study. The generation of the
FRBE/HPβCD complex was conﬁrmed, and the stoichiometry
of the complex was determined by conducting a phase
solubility study as detailed by Higuchi and Connors, with
slight modiﬁcations.18,23 Aqueous solutions (5 mL) containing

was then sonicated for 45 min using a bath sonicator
(Elmasonic P30 H, Elma Hans Schmidbauer, Singen,
Germany). Then, the complex solution was ﬁltered through
a 0.22 μm nylon ﬁlter (for puriﬁcation), then freeze-dried using
a TOPTION TOPT-10C freeze-dryer (Toption Group Co.,
Xi’an, China). A sample (25 mL) of the FRBE/HPβCD
complex solution was concentrated to 4 mL under reduced
pressure, then transferred to a 5 mL measuring. The volume
was made up to the mark with water. The concentrated
solution was ﬁltered through a 0.45 μm membrane ﬁlter before
the HPLC analysis. Similarly, the HPβCD solution (5% w/v)
was ﬁltered and analyzed by HPLC (used as blank).
2.7. 1H NMR Spectroscopy of the FRBE/HPβCD
Inclusion Complex. 1H NMR spectra of HPβCD and the
FRBE/HPβCD complex were obtained at room temperature
19547
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Figure 2. HPLC proﬁles of (A) FRBE, (B) standard ferulic acid, (C) the FRBE/HPβCD inclusion complex, and (D) plain HPβCD (blank).

various concentrations of HPβCD (0−14 mM) were added to
an excess amount of FRBE. The obtained mixtures were then
wrapped and shaken at 25 °C until equilibrium was reached.
Afterward, the mixtures were centrifuged at 5000 rpm for 15
min (Hermle Z326 K, Germany), and the supernatant was

analyzed using a UV spectrophotometer (FLUOstar Omega
microplate reader, BMG Labtech, Oﬀenburg, Germany). The
absorbance was measured at 260 nm.24,25
The stability constant (Ks) was determined using eq 1.18,24,25
19548
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Table 2. Induced Chemical Shifts (δ, ppm) of the Protons of Free HPβCD Compared to Those of the Protons of HPβCD
Complexed to FRBE
HPβCD

H-1

H-2

H-3

H-4

H-5

H-6

δHPβCD
δFRBE/HPβCD complex
Δδ

4.898
4.909
−0.011

3.548
3.557
−0.009

3.767
3.797
−0.03

3.472
3.467
0.005

3.310
3.339
−0.029

3.849
3.854
−0.004

Ks =

S
S0(1 − S)

previously identiﬁed in a pigmented rice bran variety,32 while
compound 9 was previously identiﬁed in the extracts of rice
seeds.33 Four fatty acid derivatives were identiﬁed: pentadecanoic acid (10), which was previously detected in solid-state
rice bran fermented with Pleurotus sapidus,34 methyl stearate
(18), hydroxyeicosanoic acid (19), and methyl stearate (21),
which were also identiﬁed in rice bran oil.35,36
4.2. Characterization of the Fabricated FRBE/HPβCD
Inclusion Complex. The FRBE used to form an inclusion

(1)

where S is the slope of the linear correlation and S0 is the
intrinsic solubility. The stability constant was estimated using
ferulic acid, since HPLC analysis revealed that this compound
was the marker compound.
2.10. Total Antioxidant Activity. DPPH and FRAP
assays were used to evaluate the antioxidant activities of
HPβCD, FRBE, and the FRBE-HPβCD inclusion complex as
detailed in our previously reported methods.13,14,26−28
2.11. Cytopathic Eﬀect (CPE) Reduction Antiviral
Assay. The antiviral assay was done using human inﬂuenza
H1N1 and Madin−Darby canine kidney (MDCK) cells. The
cytopathic eﬀect (CPE) reduction test was used to investigate
the antiviral activities of HPβCD, FRBE, and the FRBE/
HPβCD inclusion complex in cell culture systems as described
in our previously reported method.18
2.12. Cell Viability Assay (Sulforhodamine B Colorimetric (SRB) Assay). Cervical cancer (HeLa) and breast
adenocarcinoma (MCF-7) cell lines were treated with various
concentrations of HPβCD, FRBE, and the FRBE/HPβCD
inclusion complex. The cell viability of cancer cells was
assessed using the SRB assay, and the IC50 (μg/mL) values
were calculated using our previously reported methods.13,14
2.13. Statistical Analysis. All tests were carried out in
triplicate, and mean values were computed. Data are presented
as the mean ± SD. Data analysis was conducted using the twotailed Student’s t test at a conﬁdence interval of 95%
(considering the diﬀerence statistically signiﬁcant when the p
< 0.05).

Figure 3. Fourier transform infrared (FT-IR) spectra of (A) FRBE,
(B) HPβCD, and (C) the FRBE/HPβCD inclusion complex.

complex with HPβCD was analyzed by HPLC (measured at
325 nm), which yielded a characteristic proﬁle. The ferulic acid
content was 0.69 mg/g of extract (Figure S1). On the other
hand, the formation of the FRBE/HPβCD inclusion complex
was conﬁrmed by superimposing HPLC proﬁle of the FRBE/
HPβCD complex onto that of FRBE (Figure 2) and supported
by the FRBE-induced chemical shift of the inside protons of
the HPβCD cavity (section 4.2.1). Additionally, the FT-IR
spectra of FRBE, HPβCD, and the inclusion complex (section
4.2.2) support the inclusion of FRBE in the cavity of the
HPβCD.
4.2.1. 1H NMR Spectroscopy of the FRBE/HPβCD Inclusion
Complex. 1H NMR analyses can conﬁrm the formation of
host−guest complexation between HPβCD and other guest
molecules. Moreover, they give more insights into whether the
guest molecule is incorporated within the host hydrophobic
cavities (inclusion complexation) or externally bound to the
host molecule. In the case where the guest molecule is included
in the HPβCD cavity, remarkable upﬁeld shifts of the protons
positioned in the inner cavity (H-3 and H-5) are caused by the
shielding eﬀect of the guest. However, minor chemical shifts
(either upﬁeld or downﬁeld) will take place in the case of the
protons located on the external surface of HPβCD (H-1, H-2,
H-4, and H-6).39−42

3. RESULTS AND DISCUSSION
3.1. Analysis of the Fermented Rice Bran Extract by
UPLC/ESI-MS-MS. The LC-MS-MS analysis of the FRBE led
to the tentative identiﬁcation of 21 compounds (Figure 1 and
Table 1). Compound 1 was tentatively identiﬁed as a
nitrogenous compound, with no evidence of its molecular
formula. Pantolactone (2), 2-octanal (8), and heptanal (11)
were detected previously as volatile members of the unpleasant
aroma of the rice bran.29 Gluconic acid (3) and citric acid (5)
were previously identiﬁed in fermented rice bran extract from
aLentinus edodes liquid mycelia culture.30 In a recent study of
the eﬀect of fermentation with Trichoderma viride on the
defatted rice bran, succinic acid (4), p-coumaric acid (13),
ferulic acid (15), and p-hydroxybenzoic acid (16) were
detected as examples of organic and phenolic acids released
from the bound polyphenols. Moreover, two phenolic acids,
cinnamic acid (6) and coumaroyl quinic acid (17), were
identiﬁed; both were previously detected in the extract of rice
bran fermented by Aspergillus strains and in red- and blackpigmented rice bran, respectively.31,32 Five ﬂavonoids were
tentatively identiﬁed as irilone (7), apigenin-6/8-C-pentoside8/6-C-hexoside (9), tectoridin (12), hispidulin (14), and
dimethyl quercetin (20). Compounds 7, 12, 14, and 20 were
19549
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Figure 4. Phase solubility study of FRBE in the presence of various increasing concentrations of HPβCD.

Table 3. Phase Solubility Study Parameters and the
Estimated Stability Constant (Ks) of the FRBE/HPβCD
Inclusion Complex
complex

intercept

slope

R2

stability constant (Ks,
M−1)

FRBE/HPβCD

0.0053

0.576

0.995

256.3

Table 4. Antiviral Activities of HPβCD, FRBE, and the
FRBE/HPβCD Inclusion Complex against the Inﬂuenza A
(H1N1) Virus
sample
HPβCD
FRBE
FRBE/HPβCD inclusion
complex

CC50 (μg/
mL)

IC50 (μg/
mL)

selectivity index
(SI)

0
63.9
91.8

0
9.5
2.1

0
6.7
43.5

Table 5. In Vitro Cytotoxic Activities of HPβCD, FRBE, and
the FRBE/HPβCD Inclusion Complex against MCF-7 and
HeLa after 48 h of Treatmenta
in vitro cytotoxic activity (IC50, μg/mL)

a

cells

HPβCD

FRBE

FRBE/HPβCD

MCF-7
HeLa

310.0 ± 3.7
>300

145.9 ± 1.7
312.2 ± 2.5

0.6 ± 0.02
0.5 ± 0.01

Data represent the mean ± standard deviation of triplicate values.

shown in Table 2. In this way, it was demonstrated that the
protons inside the HPβCD cavity (H-3 and H-5) had
undergone higher FRBE-induced chemical shifts than those
on the external surface (H-1, H-2, H-4, and H-6). The stronger
upﬁeld shifts of the inner protons are attributed to the
presence of the FRBE’s aromatic rings inside the cavity of
HPβCD. These ﬁndings suggest that FRBE is complexed with
HPβCD via host−guest inclusion complexation.
4.2.2. FT-IR Analysis of the FRBE/HPβCD Inclusion
Complex. The FT-IR spectra of FRBE, HPβCD, and the
inclusion complex were compared to assess the inclusion of
FRBE in the cavity of the HPβCD (Figure 3). Changes in the
shape and intensity of the guest’s FT-IR peaks could give
insights into the formation of inclusion complexes.42
In the present study, the FT-IR spectrum of FRBE showed
four characteristic peaks at 3420.0 (−OH stretching
vibrations), 1620.0 (CO stretching), 1400.0 (−CH
bending), and 1099.0 cm−1 (C−O−C), (Figure 2). The FTIR spectra of both HPβCD and the FRBE/HPβCD complex

Figure 5. DPPH and FRAP assays of the FRBE/HPβCD inclusion
complex compared to those of FRBE. Antioxidant activities are
expressed with reference to the Trolox standard as micromoles Trolox
equivalent (TE) per milligram of the complex. Data are presented as
the mean ± standard deviation (n = 3).

Herein, the formation of the FRBE/HPβCD complex was
suggested on the basis of alterations in the chemical shifts (Δδ,
ppm) of the protons of free HPβCD as compared to the
chemical shifts the protons of HPβCD complexed to FRBE
(Figure S2). The 1H NMR chemical shifts (Δδ, ppm) of
HPβCD protons in the absence and presence of FRBE are
19550
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Figure 6. SRB assay of (A) MCF-7 and (B) HeLa cancer cell lines treated with HPβCD, FRBE, and the FRBE/HPβCD inclusion complex at
several concentrations (0.01−300 μg/mL). A statistically signiﬁcant increase in cytotoxicity was evident during treatments with the FRBE/HPβCD
inclusion complex compared to treatments with FRBE at concentrations ≥10 μg/mL (p < 0.05).

256.3 M−1, suggesting the reasonable stability of the designed
inclusion complex.25
4.2.4. Total Antioxidant Activity. The antioxidant activities
of the FRBE/HPβCD inclusion complex, HPβCD, and free
FRBE were studied and compared using DPPH and FRAP
assays (Figure 5). The ﬁndings were expressed with reference
to the Trolox standard as a micromoles Trolox equivalent
(TE) per milligram of the sample. The designed FRBE/
HPβCD inclusion complex exhibited higher antioxidant
activities of 151.30 ± 10.73 and 81.59 ± 2.58 μM TE/mg
complex as compared to those of the free FRBE (9.65 ± 2.30
and 7.09 ± 2.26 μM TE/mg complex) when assessed by
DPPH and FRAP assays, respectively. On the other hand,
HPβCD showed no antioxidant activity. The antioxidant
activity of FRBE is attributed to the presence of phenolic acids
(mainly ferulic acid) and ﬂavonoids that can scavenge free
radicals.43 Moreover, the inclusion of FRBE in the HPβCD
cavity improved the former’s water solubility and hence its
contact with the hydrophilic free radicals, leading to a dramatic
increase in its antioxidant activity compared to that of free
FRBE.44
4.2.5. Cytotoxicity and Antiviral Activity Assays. To date,
synthetic antiviral agents suﬀer from many shortcomings,
including severe adverse reactions, nonselectivity, and
resistance.18 This requires the exploration of natural
alternatives that are more potent, safe, and can overcome

are similar due to the low amount of FRBE in the medium due
to its inclusion within the HPβCD cavity. On the other hand,
some variations were observed in the peaks of the FRBE after
its inclusion in HPβCD. The peak at 1620.0 cm−1 (CO
stretching) disappeared. Additionally, the intensity of the peak
at 3420.0 cm1 (−OH stretching vibrations) was considerably
reduced. These ﬁndings suggest the inclusion of the FRBE in
the cavity of HPβCD.
4.2.3. Phase Solubility Study. The solubility of FRBE was
studied by plotting the change in its concentration with the
HPβCD concentration at 25 °C, as demonstrated in Figure 4.
Furthermore, the phase solubility study was used to determine
the stoichiometry and the stability constant of the FRBE/
HPβCD complex. The solubility of FRBE increased gradually
with the concentration of HPβCD, suggesting a linear
relationship with an R2 value of 0.995. As reported previously,
the obtained phase solubility diagram follows the AL-type
pattern, suggesting host−guest complexation with a molar ratio
of 1:1 (FRBE/HPβCD).18,24 Furthermore, the slope was more
than 0.0 and less than 1.0, conﬁrming the stoichiometry of
1:1.24 Moreover, the solubility of FRBE was about ﬁve-times
higher than its intrinsic solubility. The value of the intercept,
the slope of the phase solubility diagram, and the estimated
stability constant value of the FRBE/HPβCD complex are
presented in Table 3. The calculated stability constant was
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ally, the prepared complex demonstrated potent antiviral
activity against the H1N1 inﬂuenza virus while having a
minimal cytotoxic eﬀect on the MDCK host cells.

drug resistance. In this study, the antiviral activity of FRBE was
investigated against inﬂuenza A (H1N1) and compared to
those of the FRBE/HPβCD inclusion complex and HPβCD
using the cytopathic eﬀect (CPE) reduction assay (Table 4).
HPβCD exhibited no antiviral activity. FRBE showed
moderate antiviral activity and had a minimum impact on
MDCK host cells (IC50 of 9.5 μg/mL, CC50 of 63.9 μg/mL,
and selectivity index (CC50/IC50) of 6.7). On the other hand,
the fabricated FRBE/HPβCD inclusion complex exhibited
more potent antiviral activity (ﬁvefold) against the H1N1
inﬂuenza virus with a negligible eﬀect on the host cells (IC50 of
2.1 μg/mL, CC50 of 91.8 μg/mL, and selectivity index of 43.5).
FRBE contains ﬁve ﬂavonoid compounds, namely irilone,
apigenin-6/8-C-pentoside-8/6-C-hexoside, tectoridin, hispidulin, and dimethyl quercetin. These ﬂavonoids exert antiviral
activity by inhibiting viral RNA polymerases and proteases and,
at the same time, altering the viral proteins.45 The enhanced
antiviral activity of the prepared inclusion complex, compared
to that of free FRBE, can probably be attributed to the
increased hydrophilicity of the guest (after its complexation
with HPβCD) and, consequently, its pharmacological
activity.46
4.2.6. Cell Viability Assay. Cell viabilities of breast
adenocarcinoma (MCF-7) and cervical cancer (HeLa) cell
lines treated with various concentrations (0.01−300 μg/mL)
of HPβCD, FRBE, and the FRBE/HPβCD inclusion complex
were evaluated using the sulforhodamine B (SRB) assay (Table
5 and Figure 6). The HPβCD host displayed no signiﬁcant
cytotoxicity on either cancer cell line. After 48 h of incubation,
MCF-7 and HeLa cell lines showed a statistically signiﬁcant
decrease (p < 0.05) in cell viability when treated with the
FRBE/HPβCD inclusion complex, with IC50 values of 0.60 ±
0.02 and 0.50 ± 0.01 μg/mL, compared to those treated with
equivalent concentrations of FRBE, with IC50 values of 145.9
± 1.7 and 312.2 ± 2.5 μg/mL, respectively. The inclusion of
FRBE in the HPβCD cavity dramatically improved the
former’s cytotoxicity on both cancer cells. Several studies
reported the use of HPβCD as a host molecule for many
natural and synthetic drugs to improve their anticancer
activities.47,48 Including drugs in the HPβCD cavity oﬀers
many advantages, such as improving water solubility, stability,
and bioavailability while preserving bioactivity. Furthermore,
HPβCD protects drug molecules from any unintended
reactions that might cause their degradation and facilitates
the diﬀusion of drugs to their site of action without the loss of
their biological activities.47,48 This study also shed more light
on the potential of the anticancer activity of FRBE, which is
attributed to the phenolic acids. The main phenolic acid is
ferulic acid, which minimizes DNA single-strand breaks and
lipid peroxidation by increasing the levels of cytoprotective
enzymes and scavenging the reactive oxygen species inside the
cells.49
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5. CONCLUSIONS
In this study, Egyptian rice bran was fermented using dry yeast,
and the major phenolics were released and extracted. Twentyone diﬀerent compounds in the FRBE extract were annotated
using UPLC/ESI-MS. FRBE powder containing ferulic acid as
a marker phenolic compound was then included within the
cavity of HPβCD via host−guest interactions to improve the
former’s water solubility, stability, and biological activity. The
FRBE/HPβCD inclusion complex displayed antioxidant and
anticancer activities better than those of free FRBE. Addition-
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Preparation, characterization and antimicrobial activity of inclusion
complex of biochanin A with (2-hydroxypropyl)-β-cyclodextrin. J.
Pharm. Pharmacol. 2018, 70 (70), 1485−1493.
(20) Feddern, V.; Furlong, E. B.; Soares, L. A. Efeitos da
́
́
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